Proteasomal degradation of the Fox01 transcriptional regulator in cells transformed by the P3k and Akt oncoproteins

被引:175
作者
Aoki, M
Hao, J
Vogt, PK
机构
[1] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA
[2] Kyoto Univ, Grad Sch Med, Dept Pharmacol, Sakyo Ku, Kyoto 6068501, Japan
关键词
phosphoinositide; 3-kinase; oncogenic transformation; transcriptional repression;
D O I
10.1073/pnas.0405454101
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The P3k oncoprotein [homolog of the catalytic subunit p110alpha of class 1A phosphoinositicle 3-kinase (PI3K)] and its downstream effector Akt induce oncogenic transformation in cultures of chicken embryo fibroblasts (CEF). The winged helix transcription factor FoxO1 is a growth-attenuating and proapoptotic protein and serves as a substrate of Akt. Here we show that FoxO1 expression is constitutively suppressed in CEF transformed by P3k or Akt. The FoxO1 protein level is high in serum-starved normal CEF, but plate let-derived growth factor treatment induces rapid phosphorylation and disappearance of FoxO1. PI3K inhibitors or the proteasome inhibitor lactacystin interfere with this process. These data suggest that phosphorylation-dependent degradation of FoxO1 by means of proteasomes plays a role in oncogenic transformation by P3k and Akt. A dominant negative mutant of FoxO1 containing the repressor domain of the Drosophila Engrailed protein induces partial oncogenic transformation of CEF and interferes with FoxO1-dependent transcriptional activation. The FoxG1 oncoprotein also inhibits transcriptional activation by FoxO1. Inhibition of FoxO1, albeit by different mechanisms, appears to be a common denominator of the PI3K and FoxG1 oncogenic pathways.
引用
收藏
页码:13613 / 13617
页数:5
相关论文
共 45 条
  • [1] FoxOs at the crossroads of cellular metabolism, differentiation, and transformation
    Accili, D
    Arden, KC
    [J]. CELL, 2004, 117 (04) : 421 - 426
  • [2] Excess FoxG1 causes overgrowth of the neural tube
    Ahlgren, S
    Vogt, P
    Bronner-Fraser, M
    [J]. JOURNAL OF NEUROBIOLOGY, 2003, 57 (03): : 337 - 349
  • [3] Mechanism of activation and function of protein kinase B
    Alessi, DR
    Cohen, P
    [J]. CURRENT OPINION IN GENETICS & DEVELOPMENT, 1998, 8 (01) : 55 - 62
  • [4] The Akt kinase:: Molecular determinants of oncogenicity
    Aoki, M
    Batista, O
    Bellacosa, A
    Tsichlis, P
    Vogt, PK
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (25) : 14950 - 14955
  • [5] Aoki M, 2004, Curr Top Microbiol Immunol, V279, P321
  • [6] A role of the kinase mTOR in cellular transformation induced by the oncoproteins P3k and Akt
    Aoki, M
    Blazek, E
    Vogt, PK
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (01) : 136 - 141
  • [7] The catalytic subunit of phosphoinositide 3-kinase: Requirements for oncogenicity
    Aoki, M
    Schetter, C
    Himly, M
    Batista, O
    Chang, HW
    Vogt, PK
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (09) : 6267 - 6275
  • [8] Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1
    Biggs, WH
    Meisenhelder, J
    Hunter, T
    Cavenee, WK
    Arden, KC
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (13) : 7421 - 7426
  • [9] Myc-induced proliferation and transformation require Akt-mediated phosphorylation of FoxO proteins
    Bouchard, C
    Marquardt, J
    Brás, A
    Medema, RH
    Eilers, M
    [J]. EMBO JOURNAL, 2004, 23 (14) : 2830 - 2840
  • [10] 14-3-3 transits to the nucleus and participates in dynamic nucleocytoplasmic transport
    Brunet, A
    Kanai, F
    Stehn, J
    Xu, J
    Sarbassova, D
    Frangioni, JV
    Dalal, SN
    DeCaprio, JA
    Greenberg, ME
    Yaffe, MB
    [J]. JOURNAL OF CELL BIOLOGY, 2002, 156 (05) : 817 - 828